In CD11c-DTR tumor-bearing mice, the authors elegantly demonstrate that TIM-3 blockade coupled to administration of cisplatin, an apoptosis-inducing drug (Pruefer et al., 2008), strongly repress melanoma progression, and that TIM-3-expressing DC play a fundamental functional role in this scenario. This evidence concerns the gene HAVCR2 and melanoma.